About this FactMed analysis covering adverse side effect reports of ACULAR patients who developed ACHLORHYDRIA.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 4 individuals taking ACULAR reported ACHLORHYDRIA to the FDA. A total of 329 ACULAR drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between ACULAR and ACHLORHYDRIA. In doing so, we compare ACULAR with other drugs that cause ACHLORHYDRIA, to help you evaluate whether or not ACULAR causes ACHLORHYDRIA. Likewise, this page shows the most highly-reported side effects of ACULAR, so you can see if ACHLORHYDRIA ranks among ACULAR's most well-known side effects.
Summary Statistics
Reports of ACULAR causing ACHLORHYDRIA: 4
Reports of any side effect of ACULAR : 329
Percentage of ACULAR patients where ACHLORHYDRIA is a reported side effect: 1.2158%

FDA reports of any drug causing ACHLORHYDRIA : 27
Average percentage for all medicated patients where ACHLORHYDRIA is reported as a complication: 0.0002%

Physician opinion on ACULAR as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing ACULAR:
DRUG USE FOR UNKNOWN INDICATION ( 23 patients )
POSTOPERATIVE CARE ( 21 patients )
PRODUCT USED FOR UNKNOWN INDICATION ( 9 patients )
HYPERSENSITIVITY ( 7 patients )
UVEITIS ( 6 patients )
GLAUCOMA ( 6 patients )
PROPHYLAXIS ( 5 patients )
ILL-DEFINED DISORDER ( 4 patients )
EYE INFLAMMATION ( 3 patients )
CATARACT OPERATION ( 3 patients )
PREOPERATIVE CARE ( 2 patients )
HYPOTONY OF EYE ( 2 patients )
MACULAR OEDEMA ( 2 patients )
EYE PAIN ( 2 patients )
SURGERY ( 2 patients )
EYE PRURITUS ( 1 patients )
HERPES ZOSTER ( 1 patients )
BLEPHAROSPASM ( 1 patients )
RETINAL OEDEMA ( 1 patients )
CILIARY HYPERAEMIA ( 1 patients )
INFECTION ( 1 patients )
CORNEAL EPITHELIUM DEFECT ( 1 patients )
LACRIMATION INCREASED ( 1 patients )
CORNEAL THINNING ( 1 patients )
PAIN ( 1 patients )
EYE DISORDER ( 1 patients )
PREMEDICATION ( 1 patients )
PROCEDURAL PAIN ( 1 patients )
BLEPHARITIS ( 1 patients )
CONJUNCTIVITIS ( 1 patients )
INFLAMMATION ( 1 patients )
CORNEAL INFILTRATES ( 1 patients )
MACULAR DEGENERATION ( 1 patients )
CYST ( 1 patients )
OPHTHALMOLOGIC TREATMENT ( 1 patients )
ERYTHEMA ( 1 patients )
( 0 patients )
Drugs with high FDA adverse event association with ACHLORHYDRIA:

ASPIRIN (8 patients)
AMLODIPINE (7 patients)
COREG (6 patients)
COUMADIN (6 patients)
FLUCONAZOLE (6 patients)
GLUCOVANCE (6 patients)
GLYBURIDE (6 patients)
LASIX (6 patients)
LEVAQUIN (6 patients)
LIPITOR (6 patients)
PROMETHAZINE (6 patients)
SEROQUEL (6 patients)
AMOXICILLIN (5 patients)
CARVEDILOL (5 patients)
CIPROFLOXACIN (5 patients)
CYANOCOBALAMIN (5 patients)
DIGOXIN (5 patients)
DOXYCYCLINE (5 patients)
FOSINOPRIL SODIUM (5 patients)
GABAPENTIN (5 patients)
LISINOPRIL (5 patients)
LORCET-HD (5 patients)
MELOXICAM (5 patients)
METOLAZONE (5 patients)
NEXIUM (5 patients)
OMEPRAZOLE (5 patients)
OXYCODONE HCL AND ACETAMINOPHEN (5 patients)
ACULAR (4 patients)
GEMFIBROZIL (4 patients)
MUPIROCIN OINTMENT (4 patients)
NEORAL (4 patients)
POTASSIUM CHLORIDE (4 patients)
SILVASORB (4 patients)
TEMAZEPAM (4 patients)
TRIMETHO SULFAMETHOX (4 patients)
ACTOS (3 patients)
AGGRENOX (3 patients)
GLUCOPHAGE (3 patients)
KLOR-CON (3 patients)
LANSOPRAZOLE (3 patients)
SODIUM BICARBONATE (3 patients)
CODEINE (2 patients)
COZAAR (2 patients)
FUROSEMIDE (2 patients)
HYDROCODONE (2 patients)
MUPIROCIN (2 patients)
PANTOPRAZOLE SODIUM (2 patients)
PEG (2 patients)
POTASSIUM (2 patients)
PRILOSEC OTC (2 patients)
PROPO-K (2 patients)
RANITIDINE (2 patients)
SIMVASTATIN (2 patients)
SPIRIVA (2 patients)
SULFAMETHOXAZOLE AND TRIMETHOPRIM (2 patients)
WARFARIN SODIUM (2 patients)
ZANTAC (2 patients)
ACETYLSALICYLIC ACID SRT (1 patients)
ADVAIR HFA (1 patients)
ALBUTEROL SULFATE AUTOHALER (1 patients)
ALCOHOL (1 patients)
ALLEGRA (1 patients)
AMOXICILLIN+CLAVULANATE (1 patients)
ATENOLOL (1 patients)
AZITHROMYCIN (1 patients)
BUPROPION HCL (1 patients)
CALCIUM SUPPLEMENTS (1 patients)
CHLORTHALIDONE (1 patients)
CLOFAZIMINE (1 patients)
CLONAZEPAM (1 patients)
CLOTRIMAZOLE (1 patients)
COCAINE (1 patients)
COMBIVENT (1 patients)
CORTICOSTEROIDS (1 patients)
CYCLOBENZAPRINE (1 patients)
DARVOCET-N 100 (1 patients)
DEPO-MEDROL (1 patients)
DIET (NO INGREDIENTS/SUBSTANCES) (1 patients)
DIFLUCAN (1 patients)
DUONEB (1 patients)
EFFEXOR (1 patients)
ETHAMBUTOL HYDROCHLORIDE (1 patients)
FERROUS GLUCONATE (1 patients)
FLONASO (1 patients)
FLOR-CON (1 patients)
FLOVENT (1 patients)
INSULIN (1 patients)
LACTAID (1 patients)
LITHIUM CARBONATE (1 patients)
LOVASTATIN (1 patients)
MIRAPEX (1 patients)
MONTELUKAST SODIUM (1 patients)
NEOSTIGMINE BROMIDE (1 patients)
PAROXETINE HCL (1 patients)
PEPCID (1 patients)
POTASSIUM CHLORIDE CR (1 patients)
PRAVACHOL (1 patients)
PREDNISONE (1 patients)
PREMARIN (1 patients)
PREVACID (1 patients)
PRILOSEC (1 patients)
QUINIDINE GLUCONATE (1 patients)
RANITIDINE 150MG TABLETS, UNKNOWN MANUFACTURER (1 patients)
RANITIDINE HCL (1 patients)
RANITIDINE HYDROCHLORIDE (1 patients)
RECLAST (1 patients)
ROPINIROLE (1 patients)
SINGULAIR (1 patients)
SODIUM BICARBONATE IN PLASTIC CONTAINER (1 patients)
SYNTHROID (1 patients)
TOPROL-XL (1 patients)
TRAZODONE HCL (1 patients)
TRILEPTAL (1 patients)
TRIMEBUTINE (1 patients)
ZETIA (1 patients)
Most common side effects for patients taking ACULAR:
HYPERTENSION (42 patients)
PAIN (41 patients)
EYE PAIN (39 patients)
ANXIETY (38 patients)
VISUAL ACUITY REDUCED (38 patients)
NAUSEA (31 patients)
ULCERATIVE KERATITIS (31 patients)
FALL (30 patients)
DIZZINESS (30 patients)
VOMITING (27 patients)
DYSPNOEA (26 patients)
BLINDNESS UNILATERAL (26 patients)
VISION BLURRED (26 patients)
CHEST PAIN (26 patients)
CARDIAC FAILURE CONGESTIVE (25 patients)
ATRIAL FIBRILLATION (24 patients)
FATIGUE (24 patients)
HEADACHE (23 patients)
EYE IRRITATION (22 patients)
ASTHENIA (22 patients)
ECONOMIC PROBLEM (22 patients)
CATARACT (22 patients)
DIARRHOEA (21 patients)
PAIN IN EXTREMITY (21 patients)
BLOOD GLUCOSE INCREASED (21 patients)
DEPRESSION (20 patients)
MALAISE (19 patients)
ABDOMINAL PAIN (18 patients)
OCULAR HYPERAEMIA (17 patients)
CARDIAC DISORDER (17 patients)
INJURY (17 patients)
COUGH (16 patients)
ANAEMIA (15 patients)
DRUG INEFFECTIVE (15 patients)
HYPERHIDROSIS (15 patients)
CONTUSION (15 patients)
FEELING ABNORMAL (14 patients)
MULTIPLE INJURIES (14 patients)
UVEITIS (14 patients)
DEHYDRATION (14 patients)
ABDOMINAL DISTENSION (13 patients)
BACK PAIN (13 patients)
DRY EYE (13 patients)
SYNCOPE (13 patients)
DIABETES MELLITUS (13 patients)
VISUAL IMPAIRMENT (13 patients)
HYPOTENSION (13 patients)
CORONARY ARTERY DISEASE (13 patients)
OSTEOMYELITIS (12 patients)
PYREXIA (12 patients)
THERAPEUTIC AGENT TOXICITY (11 patients)
WHITE BLOOD CELL COUNT INCREASED (11 patients)
BLOOD GLUCOSE DECREASED (11 patients)
MUSCLE SPASMS (11 patients)
BRONCHITIS (11 patients)
TENOSYNOVITIS (11 patients)
CEREBROVASCULAR ACCIDENT (11 patients)
CHOLELITHIASIS (11 patients)
OEDEMA PERIPHERAL (10 patients)
EYE SWELLING (10 patients)
MYOCARDIAL INFARCTION (10 patients)
POST PROCEDURAL COMPLICATION (10 patients)
URINARY RETENTION (10 patients)
BREAST CANCER FEMALE (10 patients)
BREAST CYST (10 patients)
POSTOPERATIVE WOUND COMPLICATION (10 patients)
VIRAL INFECTION (10 patients)
CELLULITIS (10 patients)
MACULAR OEDEMA (10 patients)
HEART RATE IRREGULAR (9 patients)
PRESYNCOPE (9 patients)
PROTEINURIA (9 patients)
ARTHRALGIA (9 patients)
STAPHYLOCOCCAL INFECTION (9 patients)
WEIGHT INCREASED (9 patients)
EYE INJURY (9 patients)
NEUROPATHY PERIPHERAL (9 patients)
THROMBOCYTOPENIA (9 patients)
CHEST DISCOMFORT (9 patients)
CONFUSIONAL STATE (9 patients)
INTERNATIONAL NORMALISED RATIO INCREASED (9 patients)
IRITIS (9 patients)
LACRIMATION INCREASED (9 patients)
SPEECH DISORDER (9 patients)
ABDOMINAL PAIN UPPER (8 patients)
ANGINA PECTORIS (8 patients)
MUSCULOSKELETAL DISCOMFORT (8 patients)
FOOT FRACTURE (8 patients)
PALPITATIONS (8 patients)
HYPOAESTHESIA (8 patients)
CORNEAL ABRASION (8 patients)
RENAL FAILURE ACUTE (8 patients)
DYSPHAGIA (7 patients)
FASCIAL INFECTION (7 patients)
AMNESIA (7 patients)
HIP FRACTURE (7 patients)
PNEUMONIA (7 patients)
HAND FRACTURE (7 patients)
INTRAOCULAR PRESSURE INCREASED (7 patients)
EYE HAEMORRHAGE (7 patients)
RAYNAUD'S PHENOMENON (7 patients)
GASTROOESOPHAGEAL REFLUX DISEASE (7 patients)
GAIT DISTURBANCE (7 patients)
OSTEITIS (7 patients)
ROAD TRAFFIC ACCIDENT (7 patients)
BLINDNESS (7 patients)
BLOOD CHOLESTEROL INCREASED (7 patients)
INFLAMMATION (7 patients)
BLOOD PRESSURE DECREASED (7 patients)
FLUID OVERLOAD (7 patients)
URINARY TRACT INFECTION (7 patients)
DIVERTICULUM (7 patients)
CARDIO-RESPIRATORY ARREST (7 patients)
PLEURAL EFFUSION (7 patients)
ESCHERICHIA INFECTION (7 patients)
EYE DISORDER (7 patients)
INSOMNIA (7 patients)
RECTAL HAEMORRHAGE (7 patients)
SINUS BRADYCARDIA (7 patients)
FLATULENCE (7 patients)
JAW FRACTURE (7 patients)
LOSS OF CONSCIOUSNESS (7 patients)
MITRAL VALVE INCOMPETENCE (7 patients)
SKIN LACERATION (6 patients)
ANHEDONIA (6 patients)
SCOLIOSIS (6 patients)
BALANCE DISORDER (6 patients)
ILL-DEFINED DISORDER (6 patients)
BLOOD PRESSURE SYSTOLIC INCREASED (6 patients)
TRICUSPID VALVE INCOMPETENCE (6 patients)
GASTROINTESTINAL HAEMORRHAGE (6 patients)
VENTRICULAR FIBRILLATION (6 patients)
OSTEONECROSIS (6 patients)
ERYTHEMA (6 patients)
RALES (6 patients)
REFUSAL OF TREATMENT BY PATIENT (6 patients)
WOUND DEHISCENCE (6 patients)
COLONIC POLYP (6 patients)
PRURITUS (6 patients)
CORNEAL DISORDER (6 patients)
CORNEAL THINNING (6 patients)
DEEP VEIN THROMBOSIS (6 patients)
URINE ODOUR ABNORMAL (5 patients)
ACTIVITIES OF DAILY LIVING IMPAIRED (5 patients)
HAEMORRHOIDS (5 patients)
WEIGHT DECREASED (5 patients)
ULCER (5 patients)
SOMNAMBULISM (5 patients)
RASH (5 patients)
PURULENCE (5 patients)
IMPAIRED HEALING (5 patients)
ARRHYTHMIA (5 patients)
METABOLIC ENCEPHALOPATHY (5 patients)
URINARY TRACT INFECTION ENTEROCOCCAL (5 patients)
HYPERSENSITIVITY (5 patients)
PROTHROMBIN TIME PROLONGED (5 patients)
BLOOD BLISTER (5 patients)
EMOTIONAL DISORDER (5 patients)
BLOOD POTASSIUM DECREASED (5 patients)
HEAD INJURY (5 patients)
BLOOD PRESSURE INCREASED (5 patients)
SPINAL CORD COMPRESSION (5 patients)
BRADYCARDIA (5 patients)
MUSCULOSKELETAL STIFFNESS (5 patients)
TREATMENT NONCOMPLIANCE (5 patients)
TREMOR (5 patients)
DISORIENTATION (5 patients)
HAEMATOMA (5 patients)
DYSGEUSIA (5 patients)
DYSARTHRIA (5 patients)
UNRESPONSIVE TO STIMULI (5 patients)
HYPONATRAEMIA (5 patients)
GLAUCOMA (5 patients)
PULMONARY EMBOLISM (5 patients)
WHEEZING (5 patients)
INTRAOCULAR LENS IMPLANT (5 patients)
CORNEAL OEDEMA (5 patients)
SEBORRHOEIC KERATOSIS (5 patients)
CULTURE URINE POSITIVE (5 patients)
SOCIAL PROBLEM (5 patients)
NERVE INJURY (4 patients)
SURGERY (4 patients)
ACQUIRED OESOPHAGEAL WEB (4 patients)
RESIDUAL URINE (4 patients)
SINUSITIS (4 patients)
NEPHROLITHIASIS (4 patients)
SUICIDAL IDEATION (4 patients)
TOXIC ENCEPHALOPATHY (4 patients)
LIMB INJURY (4 patients)
ARTHROPATHY (4 patients)
ASTHMA (4 patients)
SLEEP-RELATED EATING DISORDER (4 patients)
FAMILY STRESS (4 patients)
MENTAL STATUS CHANGES (4 patients)
SOMNOLENCE (4 patients)
BONE PAIN (4 patients)
SPLENIC INFARCTION (4 patients)
SWELLING (4 patients)
TENDERNESS (4 patients)
TRANSIENT ISCHAEMIC ATTACK (4 patients)
RETINAL CYST (4 patients)
IMPAIRED DRIVING ABILITY (4 patients)
INTENTIONAL DRUG MISUSE (4 patients)
CORNEAL EPITHELIUM DEFECT (4 patients)
CORNEAL OPACITY (4 patients)
IRIDOCELE (4 patients)
SUBCUTANEOUS ABSCESS (4 patients)
SEPSIS (4 patients)
EYELIDS PRURITUS (4 patients)
EYELID PTOSIS (4 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent FactMed Activity for ACULAR


Issue Description / Topic Timestamp

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about ACHLORHYDRIA and ACULAR, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking ACULAR, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in ACULAR. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for ACULAR experts. If you are a healthcare provider experienced in prescribing ACULAR, please register here.
giCould not connect: